Structural and Functional Insights into α-Synuclein Fibril Polymorphism

Abnormal accumulation of aggregated α-synuclein (α-Syn) is seen in a variety of neurodegenerative diseases, including Parkinson’s disease (PD), multiple system atrophy (MSA), dementia with Lewy body (DLB), Parkinson’s disease dementia (PDD), and even subsets of Alzheimer’s disease (AD) showing Lewy-...

Full description

Bibliographic Details
Main Authors: Surabhi Mehra, Laxmikant Gadhe, Riya Bera, Ajay Singh Sawner, Samir K. Maji
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/10/1419
_version_ 1797515209929129984
author Surabhi Mehra
Laxmikant Gadhe
Riya Bera
Ajay Singh Sawner
Samir K. Maji
author_facet Surabhi Mehra
Laxmikant Gadhe
Riya Bera
Ajay Singh Sawner
Samir K. Maji
author_sort Surabhi Mehra
collection DOAJ
description Abnormal accumulation of aggregated α-synuclein (α-Syn) is seen in a variety of neurodegenerative diseases, including Parkinson’s disease (PD), multiple system atrophy (MSA), dementia with Lewy body (DLB), Parkinson’s disease dementia (PDD), and even subsets of Alzheimer’s disease (AD) showing Lewy-body-like pathology. These synucleinopathies exhibit differences in their clinical and pathological representations, reminiscent of prion disorders. Emerging evidence suggests that α-Syn self-assembles and polymerizes into conformationally diverse polymorphs in vitro and in vivo, similar to prions. These α-Syn polymorphs arising from the same precursor protein may exhibit strain-specific biochemical properties and the ability to induce distinct pathological phenotypes upon their inoculation in animal models. In this review, we discuss clinical and pathological variability in synucleinopathies and several aspects of α-Syn fibril polymorphism, including the existence of high-resolution molecular structures and brain-derived strains. The current review sheds light on the recent advances in delineating the structure–pathogenic relationship of α-Syn and how diverse α-Syn molecular polymorphs contribute to the existing clinical heterogeneity in synucleinopathies.
first_indexed 2024-03-10T06:42:17Z
format Article
id doaj.art-447d3d2097784b9482bf2f277c306c21
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T06:42:17Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-447d3d2097784b9482bf2f277c306c212023-11-22T17:33:17ZengMDPI AGBiomolecules2218-273X2021-09-011110141910.3390/biom11101419Structural and Functional Insights into α-Synuclein Fibril PolymorphismSurabhi Mehra0Laxmikant Gadhe1Riya Bera2Ajay Singh Sawner3Samir K. Maji4Department of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai 400076, IndiaDepartment of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai 400076, IndiaDepartment of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai 400076, IndiaDepartment of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai 400076, IndiaDepartment of Biosciences and Bioengineering, IIT Bombay, Powai, Mumbai 400076, IndiaAbnormal accumulation of aggregated α-synuclein (α-Syn) is seen in a variety of neurodegenerative diseases, including Parkinson’s disease (PD), multiple system atrophy (MSA), dementia with Lewy body (DLB), Parkinson’s disease dementia (PDD), and even subsets of Alzheimer’s disease (AD) showing Lewy-body-like pathology. These synucleinopathies exhibit differences in their clinical and pathological representations, reminiscent of prion disorders. Emerging evidence suggests that α-Syn self-assembles and polymerizes into conformationally diverse polymorphs in vitro and in vivo, similar to prions. These α-Syn polymorphs arising from the same precursor protein may exhibit strain-specific biochemical properties and the ability to induce distinct pathological phenotypes upon their inoculation in animal models. In this review, we discuss clinical and pathological variability in synucleinopathies and several aspects of α-Syn fibril polymorphism, including the existence of high-resolution molecular structures and brain-derived strains. The current review sheds light on the recent advances in delineating the structure–pathogenic relationship of α-Syn and how diverse α-Syn molecular polymorphs contribute to the existing clinical heterogeneity in synucleinopathies.https://www.mdpi.com/2218-273X/11/10/1419α-synucleinamyloidpolymorphssynucleinopathies
spellingShingle Surabhi Mehra
Laxmikant Gadhe
Riya Bera
Ajay Singh Sawner
Samir K. Maji
Structural and Functional Insights into α-Synuclein Fibril Polymorphism
Biomolecules
α-synuclein
amyloid
polymorphs
synucleinopathies
title Structural and Functional Insights into α-Synuclein Fibril Polymorphism
title_full Structural and Functional Insights into α-Synuclein Fibril Polymorphism
title_fullStr Structural and Functional Insights into α-Synuclein Fibril Polymorphism
title_full_unstemmed Structural and Functional Insights into α-Synuclein Fibril Polymorphism
title_short Structural and Functional Insights into α-Synuclein Fibril Polymorphism
title_sort structural and functional insights into α synuclein fibril polymorphism
topic α-synuclein
amyloid
polymorphs
synucleinopathies
url https://www.mdpi.com/2218-273X/11/10/1419
work_keys_str_mv AT surabhimehra structuralandfunctionalinsightsintoasynucleinfibrilpolymorphism
AT laxmikantgadhe structuralandfunctionalinsightsintoasynucleinfibrilpolymorphism
AT riyabera structuralandfunctionalinsightsintoasynucleinfibrilpolymorphism
AT ajaysinghsawner structuralandfunctionalinsightsintoasynucleinfibrilpolymorphism
AT samirkmaji structuralandfunctionalinsightsintoasynucleinfibrilpolymorphism